T2DM patients on dual antiplatelet therapy were assigned to receive cilostazol 100 mg or placebo twice daily for 14 days and afterwards crossed-over treatment assignments for another 14 days.

• 方法和结果：本研究是一个前瞻性，双盲，双模拟、安慰剂对照，随机、交叉的血小板功能研究。